ARTICLE | Clinical News
Sublivac FIX Phleum pratense: Completed Phase II enrollment
December 24, 2012 8:00 AM UTC
HAL Allergy completed enrollment of over 250 patients with persistent allergic rhinitis or rhinoconjunctivitis in the double-blind, placebo-controlled, European Phase II trial evaluating Sublivac FIX ...